Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We have identified 6 sera containing autoantibodies to CD4 in 174 human immunodeficiency virus-type (HIV-1) positive sera tested in an antigen-capture enzyme-linked immunosorbent assay (ELISA) using sCD4, and none in 34 HIV type 2 sera. These autoantibodies do not bind to cellular CD4, but react with sCD4 to increase its binding in ELISA to monoclonal antibodies and the HIV surface glycoprotein gp120. The effect of CD4 autoantibodies is mimicked by monoclonal antibodies to the third and fourth domains of CD4. The enhanced sCD4 binding to gp120 in ELISA is reflected by a reduction in the concentration of sCD4 required to neutralize HIV-1 and HIV-2 infection in tissue culture when CD4 autoantibodies or the relevant monoclonal antibodies were present.

Original publication

DOI

10.1089/aid.1990.6.1273

Type

Journal article

Journal

AIDS Res Hum Retroviruses

Publication Date

11/1990

Volume

6

Pages

1273 - 1279

Keywords

Amino Acid Sequence, Animals, Antibodies, Monoclonal, Autoantibodies, CD4 Antigens, Cell Line, Cricetinae, Enzyme-Linked Immunosorbent Assay, HIV Envelope Protein gp120, HIV Infections, HIV-1, Humans, Male, Molecular Sequence Data, Neutralization Tests, Solubility